AccessPak for HIV PEP Expanded with Kaletra and Skyrizi Injection
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Skyrizi Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Skyrizi topical
- AccessPak for HIV PEP Expanded with Kaletra-Sleep Aid
- AccessPak for HIV PEP Expanded with Kaletra-Sleep Aid Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Sleepinal
- AccessPak for HIV PEP Expanded with Kaletra-Slo-Niacin
- AccessPak for HIV PEP Expanded with Kaletra-Slow Fe
- Skyrizi Injection-AccessPak for HIV PEP Expanded with Viracept
- Skyrizi Injection-Accolate
- Skyrizi Injection-Accretropin
- Skyrizi Injection-Accucaine
- Skyrizi Injection-AccuHist Drops
- Skyrizi Injection-AccuHist PDX Drops